Dr. Christopher W. Ryan
Claim this profileOregon Health and Science University
About Christopher W. Ryan
Education:
- Earned an MD (Doctor of Medicine) from an unspecified institution.
Experience:
- Completed Residency in Internal Medicine at the University of Chicago in 1997.
- Completed Fellowship in Hematology/Oncology at the University of Chicago in 2000.
- Certified by the American Board of Internal Medicine (Medical Oncology) since 2000.
- Member of the American Society of Clinical Oncology.
- Specializes in the treatment of sarcomas and genitourinary cancers.
- Actively involved in providing patients with the latest treatments through clinical trials.
Area of expertise
Cancer
Christopher W. Ryan has run 10 trials for Cancer. Some of their research focus areas include:
Kidney Cancer
Christopher W. Ryan has run 7 trials for Kidney Cancer. Some of their research focus areas include:
Affiliated Hospitals
Oregon Health And Science University
Oregon Health & Science University
Clinical Trials Christopher W. Ryan is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting
1 award
Phase 2
10 criteria
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting
1 award
Phase 2
21 criteria
More about Christopher W. Ryan
Clinical Trial Related
3 years of experience running clinical trials · Led 23 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Christopher W. Ryan has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- Doxorubicin
- Placebo
- Paclitaxel
Breakdown of trials Christopher W. Ryan has run
Cancer
Kidney Cancer
Bladder Cancer
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher W. Ryan specialize in?
Christopher W. Ryan focuses on Cancer and Kidney Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are PD-L1 positive.
Is Christopher W. Ryan currently recruiting for clinical trials?
Yes, Christopher W. Ryan is currently recruiting for 6 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Christopher W. Ryan has studied deeply?
Yes, Christopher W. Ryan has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with Christopher W. Ryan?
Apply for one of the trials that Christopher W. Ryan is conducting.
What is the office address of Christopher W. Ryan?
The office of Christopher W. Ryan is located at: Oregon Health and Science University, Portland, Oregon 97239 United States. This is the address for their practice at the Oregon Health and Science University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.